2/ They've kindly agreed to provide a coupon code "CITIZEN" for their package to help get both a discount and allow opting in your anonymized data to our OYL anonymous data pool. (Just like we do at our site)
No, there's no $$$ or compensation for us or anything like that...
3/ ... Which might seem confusing since they are technically a competitor given they offer bloodwork as well.
But hello -- @siobhan_huggins and I are *always* game for *everyone* finding what works for them. And seriously, I think this platform is a strong step forward.
4/ As I said frequently in the video (and here), cardiometabolic health doesn't get nearly the level of attention it deserves relative to how much it matters.
So again, props to Bill and his team for putting this thing together.
2/ Occasionally I get a doctor (often a Dermatologist) ask if I've checked for hypothyroidism given it can be associated with loss of the outer eyebrow.
However, this is usually resolved when they see my eyebrows up close given it doesn't follow the same pattern...
3/ Often there is a pronounced pinching or abrupt halt in the pattern of spread. But to be sure, this is more of what I hear from them. I haven't researched much on it given I already knew this pattern was common in my family-- but this study was helpful👇 ncbi.nlm.nih.gov/pmc/articles/P…
But in this late moment of calm before the weekend, I'm finding myself truly humbled that our #LMHRpaper is finalized and has crossing so many interested eyes.
I hope many will agree with us this phenomenon is well worth researching.
2/ Via @nicknorwitz: "... this paper has stimulated vigorous discussion, risen to the top of its journal for all time reads, and is among the top 15 trending papers across all American Society of Nutrition associated journals for the year 2021." nutrition.org/15-trending-nu…
3/ There's quite a bit more work in the pipeline from the many great collaborators I have the honor to be working with. We're passionately working on a #LipidEnergyModel paper, the #LMHRstudy (currently underway), and a couple other projects I can't announce just yet...
One thing that still surprises me is when I'm tweeting or retweeting opinion, articles, etc that are generally pro #LDL#Cholesterol-lowering or LDL-as-problematic (such as recently) I get some pushback...
2/ If you've followed me a long time, you should know this is something I'm proactive about doing -- in fact, I'm more active at doing it now than ever.
If you've only heard the ⬆️LDL isn't-so-bad case, please hear out the mainstream case on how ⬆️LDL *is* bad... #NoEchoChambers
3/ If you somehow hadn't already heard, I literally spearheaded a crowdfunding campaign for an IRB-approved study with longitudinal CCTAs to track plaque development
Why? Because we don't know what the risk levels are for this context. If we did, there'd be no need for the study
1/ Yes, will comment on it in time as I have some follow up questions and comments -- but for the moment, I want to reemphasize how much I appreciate @deirdre_tobias publishing the baseline charts, making the code available, and overall devoting her time to this project...
2/ Seeing this progress and unfold over a matter of weeks is fantastic. I'm used to either getting a "sneak preview" of what an analysis might show with a given dataset or be told it will require full publication (many months and dollars down the road) in order to be public...
3/ In other words, I wish we could get this kind of turnaround and transparency on every major dataset. @deirdre_tobias has effectively done something I've been asking after for years -- and she did so at no cost.
That's worth its own distinction and one I certainly laud.